Sign in
DMAAU Stock Price, Chart, Stats & News
Drugs Made In America Acquisition Corp. Units
Save
Drugs Made In America Acquisition Corp. Units (DMAAU) does not currently pay a dividend.
357.82M
Market cap
58.55x
Current P/E
–
Forward P/E
DMAAU chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 2.41% |
ROE | 3.35% |
D/E | – |
Interest coverage ratio | – |
DMAAU valuation
P/E | 58.55x |
P/S | – |
P/B | 1.05x |
P/CF | -583.15x |
P/FCF | -849.80x |
P/OCF | -583.15x |
PEG | 688.04x |
EV multiple | -484.39x |
About
Drugs Made In America Acquisition Corp. operates as a special purpose acquisition company (SPAC). Its primary objective is to achieve a business combination, which may involve a merger, an asset acquisition, a share exchange, or a corporate restructuring, with one or more existing enterprises. The firm was established on May 23, 2024, and maintains its principal office in Fort Lauderdale, Florida.
Similar securities
Based on sector and market capitalization
Report issue